Free Cash Flow

Processa Pharmaceuticals completes enrollment for a pivotal analysis of its NGC-Cap therapy, offering new hope for a safer, more effective cancer treatment.

With promising 3-year vision data and a manufacturing breakthrough, Lineage is pioneering 'off-the-shelf' cell therapies for blindness, diabetes, and more.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

EchoStar's soaring stock price has triggered a conversion option for its 2030 notes, creating a pivotal choice between debt, cash, and equity.

Scorpio Tankers locks in a five-year, $105M charter deal for two tankers, a strategic move to ensure revenue stability amid a volatile shipping market.

In a major win, Rockwell Medical extends its DaVita supply deal through 2026 with a price hike, underscoring the value of its reliable supply chain.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Shipping giant Costamare Inc. reaffirms its financial strength with consistent shareholder payouts, backed by a strong market and strategic growth.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

Cannabix Technologies lands its first international order for its smart breathalyzer in Australia, a move that validates its tech and reshapes its finances.

As Wesdome Gold Mines targets mid-tier status, the appointment of financial expert Faheem Tejani signals a strategic move to bolster financial oversight.

Facing a Nasdaq delisting threat, China-based WF International has 180 days to revive its stock after a dramatic collapse since its April IPO.

Hyatt finalizes a $2B asset sale to Tortuga Resorts, advancing its asset-light strategy while navigating hurricane recovery in the Caribbean.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

Fresh off a successful IPO, Ceribell is set to showcase its revolutionary AI-powered EEG system, a device already changing outcomes in ICUs nationwide.

Riding a wave of record revenue and a favorable reimbursement outlook, iRhythm's upcoming JPM presentation is a key test for its 2026 growth strategy.

As CooperCompanies heads to the J.P. Morgan conference, all eyes are on CEO Al White's strategic vision for its dual vision and women's health units.

After eliminating over $10.7M in debt, cannabis operator LEEF Brands leverages strong Q3 growth to fuel major expansion in California and New York.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.